OPPI Anti-Counterfeiting Guidelines

Counterfeit medicines represent an unacceptable risk to patient safety whilst at the same time jeopardizing the original manufacturer’s image, reputation and, in extreme cases, their economic viability. It is therefore imperative that every manufacturer of prescription and OTC medicines has in place an effective operating procedure, to make counterfeiting difficult and, to facilitate detection and investigation.

Price: (excluding Service Tax) 
Local – Indian Rupees: 150
International - U.S.$ 10

Download Free 

Order Form